BioSpectra has expanded its pilot and kilo-scale production area, R&D Staff and Engineering support team to better service the needs of our customers seeking the synthesis of smaller volumes of proprietary small-molecule excipients and APIs. In addition, BioSpectra has successfully developed synthetic paths for several key Biological Buffers currently at risk of disruption in supply and consistent quality due to overseas supply chains. The new production facilities are housed at BioSpectra’s FDA registered and inspected, 150,000 square foot GMP facility located in Bangor PA, USA. BioSpectra exclusively manufactures in the USA, premium GMP pharmaceutical ingredients, GMP process chemicals and GMP compounded solutions and solvents.